| Fall-related fracture group (n = 28) | Non fall-related fracture group (n = 849) | p value | ||||
---|---|---|---|---|---|---|---|
Age (years old) | 82.3 | ± | 5.9 | 79.1 | ± | 4.6 | 0.001 |
Height (cm) | 151.9 | ± | 9.3 | 154.6 | ± | 8.7 | 0.121 |
Weight (kg) | 54.2 | ± | 9.0 | 57.0 | ± | 9.6 | 0.121 |
BMI (kg/m2) | 23.4 | ± | 3.1 | 23.8 | ± | 3.3 | 0.528 |
MMSE | 26.6 | ± | 2.7 | 27.5 | ± | 2.3 | 0.058 |
MOS score | 3.9 | ± | 1.8 | 4.3 | ± | 1.7 | 0.227 |
Energy intake | 2025 | ± | 640 | 1998 | ± | 495 | 0.782 |
Gender (male) | Â | 28.6% | Â | Â | 44.8% | Â | 0.096 |
Stroke history | Â | 7.1% | Â | Â | 5.3% | Â | 0.671 |
Diabetes history | Â | 17.9% | Â | Â | 13.8% | Â | 0.541 |
Kidney disease history | Â | 0.0% | Â | Â | 7.3% | Â | 0.997 |
Osteoporosis history | Â | 3.6% | Â | Â | 7.3% | Â | 0.462 |
Cancer history | Â | 21.4% | Â | Â | 12.8% | Â | 0.192 |
Use of stabilizer | Â | 10.7% | Â | Â | 13.3% | Â | 0.691 |
Use of hypnotic | Â | 7.1% | Â | Â | 10.7% | Â | 0.549 |
Use of steroid | Â | 3.6% | Â | Â | 4.0% | Â | 0.908 |
Use of supplement | Â | 10.7% | Â | Â | 18.1% | Â | 0.589 |
Use of HRT | Â | 39.3% | Â | Â | 3.7% | Â | 0.998 |
Smoking habit | Â | 21.4% | Â | Â | 43.7% | Â | 0.026 |
Drinking habit | Â | 35.7% | Â | Â | 52.1% | Â | 0.085 |
Experience of falls in previous 6 months | Â | 25.0% | Â | Â | 16.5% | Â | 0.252 |